Status | Study |
Recruiting |
Study Name: Biomarkers and Volumetric Capnography in BPD Condition: Bronchopulmonary Dysplasia Date: 2014-02-25 |
Not yet recruiting |
Study Name: Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study Condition: Bronchopulmonary Dysplasia Date: 2013-06-25 Interventions: Drug: Inhaled budesonide Inhal |
Completed |
Study Name: Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Prematurity Date: 2012-10-29 |
Not yet recruiting |
Study Name: Clarithromycin Prophylaxis in Preterm Infants Colonisation With Ureaplasma Urealyticum and Mycoplasma Hominis Condition: Bronchopulmonary Dysplasia Date: 2012-07-22 Interventions: Drug: clarithromycin treatment for prophylaxis of bronchopulmonary dysplasia |
Completed |
Study Name: Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2012-07-17 Interventions: Other: blood sampling blood sampling |
Active, not recruiting |
Study Name: Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2012-06-27 Interventions: Biological: Pneumostem® A single intratracheal admini |
Completed |
Study Name: Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2011-09-16 |
Recruiting |
Study Name: Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD) Condition: Bronchopulmonary Dysplasia Date: 2011-06-13 Interventions: Drug: Inhaled extra-fine hydrofluoalkane-beclomethasone (QVAR) Infants will be randomized for Inhaled QV |
Completed |
Study Name: Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia Condition: Bronchopulmonary Dysplasia Date: 2011-02-11 Interventions: Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells Dose A - 10 million cells per kg D |
Completed |
Study Name: Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants. Condition: Bronchopulmonary Dysplasia Date: 2010-12-28 Interventions: Drug: Infasurf Endotracheal in |